2011
DOI: 10.1007/s00408-011-9304-5
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters

Abstract: The aim of this study was to prospectively evaluate the prevalence of pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF). One hundred thirty-nine patients (101 male, mean age = 68.6 ± 9 years), with confirmed IPF and who were admitted to eight Pulmonary Departments in Greece between November 2005 and December 2006 were included in the study. Pulmonary artery systolic pressure (PASP) was estimated by echocardiography, and PH was defined as PASP > 36 mmHg. We compared demographics, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 27 publications
1
24
0
2
Order By: Relevance
“…In general, the prevalence of PH was similar in studies from Europe [18,25,[40][41][42][43][44][45][47][48][49], North America [5,6,26,28,46,[50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67], Asia and Africa [37,[68][69][70][71][72][73][74][75], although the majority of evidence was reported from North America (n=23, 53%). Across studies, the prevalence of PH among IPF patients ranged from 3% to 86%; most estimates tended to be between 30% and 50% (figure 3) [25, 43, 44, 47, 50, 52-66, 68, 71-73].…”
Section: Pulmonary Hypertensionmentioning
confidence: 84%
“…In general, the prevalence of PH was similar in studies from Europe [18,25,[40][41][42][43][44][45][47][48][49], North America [5,6,26,28,46,[50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67], Asia and Africa [37,[68][69][70][71][72][73][74][75], although the majority of evidence was reported from North America (n=23, 53%). Across studies, the prevalence of PH among IPF patients ranged from 3% to 86%; most estimates tended to be between 30% and 50% (figure 3) [25, 43, 44, 47, 50, 52-66, 68, 71-73].…”
Section: Pulmonary Hypertensionmentioning
confidence: 84%
“…On the other hand, these vascular derangements may pave the way for the development of pulmonary hypertension (PH) as a result of irreversible vascular remodeling and increase in vascular resistances [4]. PH is common in IPF even in subjects with no significant functional impairment [9]. It is associated with an increased risk of death [10] and with primary graft dysfunction in transplanted patients [11].…”
Section: Introductionmentioning
confidence: 99%
“…Impaired pulmonary vascular blood flow due to PH results in reduced exercise capacity and disproportional dyspnoea [6], [8], [9], [10]. Peak oxygen uptake (peakVO 2 ) assessed by cardiopulmonary exercise testing (CPET) as well as 6 minute walk distance are significantly impacted by PH [6], [8], [11].…”
Section: Introductionmentioning
confidence: 99%